Successful rescue TNF-α blocking for Mycobacterium genavense – Related immune reconstitution inflammatory syndrome: A case report

Successful rescue TNF-α blocking for Mycobacterium genavense – Related immune reconstitution inflammatory syndrome: A case report

Immune reconstitution inflammatory syndrome (IRIS) has been reported in immunocompromised patients with disseminated Mycobacterium genavense. Management relies on high-dose corticosteroids.We describe two cases of late-onset corticosteroid-refractory IRIS related to disseminated infection in a HIV-p...

Full description

Bibliographic Details
Main Authors:	Hugo Bes-Berlandier, Margaux Garzaro, Claire Rouzaud, Sylvain Bodard, Emmanuelle Bille, Maxence Ficheux, Dominique Cazals-Hatem, Nicolas Veziris, Fanny Lanternier, Olivier Lortholary
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Heliyon
Subjects:	mycobacterium genavense IRIS Monoclonal anti-TNF-α antibody Infliximab Case report
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024053726

Similar Items

Pseudotumor of the skin due to Mycobacterium genavense
by: Suguru Kurosawa, et al.
Published: (2023-09-01)

Hodgkin Lymphoma after Disseminated Mycobacterium genavense Infection, Germany
by: Janina Trauth, et al.
Published: (2022-07-01)

Disseminated Mycobacterium genavense infection in an otherwise healthy child: a clinical case and literature review
by: Dolgopolov I.S., et al.
Published: (2023-12-01)

Disseminated <i>Mycobacterium genavense</i> Infection Mimicking Sarcoidosis: A Case Report and Review of Literature on Japanese Patients
by: Ryo Ogata, et al.
Published: (2023-08-01)

Monitored therapy of sporadic mycobacteriosis caused by Mycobacterium genavense in Atlantic canaries (Serinus canaria) and Bengalese finch (Lonchura striata)
by: Ledwoń Aleksandra, et al.
Published: (2021-12-01)

Immune reconstitution inflammatory syndrome in tuberculous pleurisy and ulcerative colitis: a case report
by: Federico Piffer, et al.
Published: (2019-09-01)

Mycobacterium genavense Causing Lung Abscess in an Immunocompetent Individual
by: Ria Lawrence, et al.
Published: (2021-01-01)

Sarcoid-like lesions obfuscating the diagnosis of disseminated Mycobacterium genavense infection in a patient with IL-12Rβ1-associated immunodeficiency
by: Sara Denicolò, et al.
Published: (2022-10-01)

Immune Reconstitution Inflammatory Syndrome with Recurrent Paradoxical Cerebellar HIV-Associated Progressive Multifocal Leukoencephalopathy
by: Paola Frattaroli, et al.
Published: (2021-06-01)

The Role of Non-Selective TNF Inhibitors in Demyelinating Events
by: Line Buch Kristensen, et al.
Published: (2021-01-01)

High Levels of TNF-α and TIM-3 as a Biomarker of Immune Reconstitution Inflammatory Syndrome in People with HIV Infection
by: Lucero A. Ramon-Luing, et al.
Published: (2021-06-01)

Evaluation of Lupus Cases Related to TNF Inhibitors in Children
by: Şeyma Türkmen, et al.
Published: (2023-12-01)

Immune reconstitution inflammatory syndrome, a controversial burden in the East African context: a systematic review and meta-analysis
by: Alene Geteneh, et al.
Published: (2023-08-01)

Therapeutic Drug Monitoring of Anti-TNFα Inhibitors: A Matter of Cut-Off Ranges
by: Stefania Cheli, et al.
Published: (2023-06-01)

A case of syphilis associated with immune reconstitution inflammatory syndrome and review of the literature
by: Luca Pipitò, et al.
Published: (2023-05-01)

Clinical management of severe active ulcerative colitis in the TNF-a inhibitors era
by: Andrea Calafiore, et al.
Published: (2013-12-01)

Double trouble: Concomitant unmasking and paradoxical immune reconstitution inflammatory syndrome in a patient with newly diagnosed HIV
by: Jennifer Makhoul, et al.
Published: (2022-01-01)

Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease
by: Albert Boronat-Toscano, et al.
Published: (2022-09-01)

A mouse model for ulcerative colitis based on NOD-scid IL2R γnull mice reconstituted with peripheral blood mononuclear cells from affected individuals
by: Pia Palamides, et al.
Published: (2016-09-01)

Late onset CNS Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient
by: Alejandro eHornik, et al.
Published: (2013-02-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
by: V N Amirdzhanova, et al.
Published: (2010-12-01)

Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome—An Extempore Game of Misfiring with Defense Arsenals
by: Ramachandran Vignesh, et al.
Published: (2023-01-01)

Latent Tuberculosis Infection and Tuberculosis Development in Children Treated with Anti-TNF-α Agents
by: Aykut EŞKİ, et al.
Published: (2023-07-01)

Association between HLA DNA Variants and Long-Term Response to Anti-TNF Drugs in a Spanish Pediatric Inflammatory Bowel Disease Cohort
by: Sara Salvador-Martín, et al.
Published: (2023-01-01)

The Role of Low-Dose Oral Methotrexate in Increasing Anti-TNF Drug Levels and Reducing Immunogenicity in IBD
by: Kathryn Demase, et al.
Published: (2023-06-01)

An in vitro study elucidating the synergistic effects of aqueous cinnamon extract and an anti-TNF-α biotherapeutic: implications for a complementary and alternative therapy for non-responders
by: Shubrata Khedkar, et al.
Published: (2024-03-01)

Focus on Anti-Tumour Necrosis Factor (TNF)-α-Related Autoimmune Diseases
by: Loris Riccardo Lopetuso, et al.
Published: (2023-05-01)

Development of Anti-bodies against Infliximab in Iraqi Patients with Rheumatoid Arthritis.
by: Mohammed A. Al-Karkhi, et al.
Published: (2015-10-01)

Therapeutic Drug Monitoring in Inflammatory Bowel Disease
by: Manoel Alvaro de Freitas Lins Neto, et al.
Published: (2023-12-01)

Immune reconstitution inflammatory syndrome in splenic Pneumocystis jirovecii infection: A case report
by: Hiroki Kojima, et al.
Published: (2023-01-01)

Biosimilar competition in European markets of TNF-alpha inhibitors: a comparative analysis of pricing, market share and utilization trends
by: Elif Car, et al.
Published: (2023-04-01)

TNF-alpha blockers in inflammatory bowel diseases: Practical consensus recommendations and a user's guide
by: C Felley
Published: (2009-05-01)

Lymphoprolipherative skin reactions induced by anti-TNFα: an open question
by: Vasiliki Nikolaou, et al.
Published: (2020-01-01)

Inhibition of TNF-α Restores Muscle Force, Inhibits Inflammation, and Reduces Apoptosis of Traumatized Skeletal Muscles
by: Ioannis Stratos, et al.
Published: (2022-08-01)

Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review
by: Jiaying Chen, et al.
Published: (2023-10-01)

Hyperinflammatory syndrome in a paediatric patient with a recent diagnosis of HIV/AIDS infection: hemophagocytic lymphohistiocytosis or immune reconstitution syndrome?
by: Fabrizio Leone, et al.
Published: (2023-07-01)

Correlation of anti-TNF-a biological therapy with periodontal conditions and osteonecrosis in autoimmune patients: A systematic review
by: Rana Majdi Abunemer, et al.
Published: (2023-11-01)

Comments on: Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children
by: Paula Zapata-Cobo, et al.
Published: (2023-10-01)

Whole Transcription Profile of Responders to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2021-01-01)

Gene Signatures of Early Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Disease
by: Sara Salvador-Martín, et al.
Published: (2020-05-01)